Pfizer tablets significantly reduce the risk of death from COVID-19, the company says

Antiviral drugs are coming. A day after the UK approved MSD / Ridgeback’s molnupiravir for the treatment of vulnerable people infected with COVID-19 was reported by Pfizer on Friday to have an 89 percent reduced risk of hospitalization or death with its antiviral candidate. An interim analysis showed that its antiviral treatment, called Paxlovid, compared … Read more

error: Content is protected !!